Skip to main navigation
AC Immune - World-class science that makes a difference in patients' lives
  • About Us
    About us Our Teams Our Partners Our R&D Strategy
  • Our Science
    Our Science Pioneering Precision Medicine Technology Platforms Scientific Publications
  • Our Pipeline
    Our Pipeline Therapeutic Focus Clinical Trials
  • Investors
  • Careers
    Careers Join us
Investors
  • Why Invest
  • Key Figures
  • Share Price
  • Analyst Coverage
  • Milestones
  • Key Shareholders
  • FAQ
  • Contacts & Resources
Press Releases
In the News
Events & Presentations
Corporate Governance
Financial Reporting
Annual Reports
search

Press Release Details

  1. Home
  2. Investors
  3. Press Releases
  4. Development of new medicines for memory impairment

Development of new medicines for memory impairment

Jan 17, 2012
English 60.4 KB
Deutsch 61.8 KB
722023.pdf 60.4 KB

Shareholder Tools

Print Page
Print Page
Email Alerts
Email Alerts
Information Request
Information Request
Contact IR
Contact IR

AC Immune SA

EPFL Innovation Park-Building B 1015 Lausanne / Switzerland
  • Phone: +41 21 345 91 21
  • Fax: +41 21 345 91 20
  • Email: info@acimmune.com
  • Home
  • About Us
  • Our Science
  • Our Pipeline
  • Investors
  • Careers

Stay in touch

Get to know us

Social Links (Redesign)

  •

© 2026 AC Immune SA

Legal Links (Redesign)

  • Privacy policy
  • Supplier information
  • Terms of use